SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (267)	1/19/1999 1:49:00 PM
From: Mike McFarland	Read Replies (1) of 579

SIBIA Neurosciences Announces Granting of Key Foreign Patents for Technology Involved in its Recent Successful Litigation Against Cadus Pharmaceuticals, Inc. biz.yahoo.com Dr. William T. Comer, President and CEO at SIBIA Neurosciences stated, ''Having successfully validated our patent rights to the jury in our litigation with Cadus Pharmaceuticals, Inc. in U.S. District Court, we are delighted that the Canadian and European Patent Offices have also recognized the novelty of our pioneering invention. We believe that this technology is being used by a number of biotechnology and pharmaceutical companies and are presently reviewing our licensing strategies for this technology.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next